- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01437826
Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial
September 19, 2011 updated by: Luigina Bonelli, IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Evaluation of the Efficacy of a Combination of Micronutrients (Vitamin A, C, E, Selenium and Zinc) in Reducing the Incidence of Colorectal Metachronous Adenomas. A Double Blind, Phase III, Randomized, Placebo-controlled Trial
The trial was aimed at evaluating the efficacy of a multiagent antioxidant compound (vitamin A, C, E, selenium and zinc) in reducing the incidence of metachronous adenomas of the large bowel after endoscopic polypectomy.
This is a randomized study: a 50% reduction in the incidence of metachronous adenomas was expected in patients allocated to the "active" compound (intervention) arm as compared to those assigned to a placebo.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Adenomatous polyps (or adenoma) are benign lesions of the large bowel that are frequent in people aged 60 or more: about one in four of them has at least one adenoma.
In time, adenoma could progress to cancer.
Even though only a small rate of adenomas will develop into cancer almost 70-80% of colorectal cancer origin from an adenoma and colorectal cancer is one of the most frequent malignant tumors in the western world.
Several epidemiological studies showed that subjects who had low intake and/or low blood levels of selenium were at increased risk of developing colorectal cancer.
Study Type
Interventional
Enrollment (Actual)
411
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Genova, Italy, 16132
- IRCCS Azienda Ospedale Università San Martino - IST Istituto Nazionale per la Ricerca sul Cancro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 25-75 years
- at least one histologically confirmed adenoma endoscopically removed from the large bowel resulting in a polyp-free colon-rectum (clean colon).
Exclusion Criteria:
- polypectomy performed more than 6 months before enrolment in the trial
- history of Familial Adenomatous Polyposis
- inflammatory bowel disease
- adenoma with invasive carcinoma
- ten or more adenomas
- large sessile adenoma (3 cm or more
- colorectal resection
- invasive cancer at any site
- life-threatening and/or chronic heart, liver or kidney diseases
- current use of vitamin or calcium supplements
- mental disability
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: antioxidants
tablets composed of 200 mcg selenium [as l-selenomethionine], 30 mg zinc, 2 mg vitamin A [retinol], 180 mg vitamin C [ascorbic acid] and 30 mg vitamin E [D-α-tocopherol acetate]
|
tablets composed of 200 mcg selenium [as l-selenomethionine], 30 mg zinc, 2 mg vitamin A [retinol], 180 mg vitamin C [ascorbic acid] and 30 mg vitamin E [D-α-tocopherol acetate]
Other Names:
|
Placebo Comparator: Sugar pill
placebo had an identical appearance as intervention
|
placebo had an identical appearance as intervention
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
occurrence of metachronous adenomas or cancer detected during endoscopic follow up examinations
Time Frame: five years
|
five years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Luigina A Bonelli, MD, IRCCS Azienda Ospedale Università San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genova - Italy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 1988
Primary Completion (Actual)
June 1, 1996
Study Completion (Actual)
June 1, 1996
Study Registration Dates
First Submitted
September 14, 2011
First Submitted That Met QC Criteria
September 19, 2011
First Posted (Estimate)
September 21, 2011
Study Record Updates
Last Update Posted (Estimate)
September 21, 2011
Last Update Submitted That Met QC Criteria
September 19, 2011
Last Verified
September 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IST-1988
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Adenomas
-
Martin-Luther-Universität Halle-WittenbergUniversity of Ulm; Deutsche Krebshilfe e.V., Bonn (Germany); KKS NetzwerkCompletedColorectal Serrated Adenomas | Colorectal Tubular Adenomas | Colorectal Villous Adenomas | Colorectal Tubulovillous AdenomasGermany
-
Presidio Ospedaliero Santa BarbaraCompletedPain | Colorectal Cancer | Colorectal AdenomasUnited States, Czech Republic, Italy
-
Kliniken Ludwigsburg-Bietigheim gGmbHOvesco Endoscopy AGUnknownColorectal Adenomas | Submucosal TumorsGermany
-
Xijing Hospital of Digestive DiseasesCompleted
-
Helios Albert-Schweitzer-Klinik NortheimCompletedColorectal Polyps | Colorectal AdenomasGermany, Poland
-
Presidio Ospedaliero Santa BarbaraCompletedPain | Colorectal Cancer | Colorectal AdenomasUnited States, Italy
-
Presidio Ospedaliero Santa BarbaraCompletedPain | Colorectal Cancer | Colorectal AdenomasUnited States, Italy
-
Genomictree, Inc.Samsung Medical Center; Pusan National University Hospital; Asan Medical Center; Seoul National University Hospital and other collaboratorsRecruitingColorectal Cancer | Advanced Colorectal Neoplasm | Advanced Adenomas | Non-neoplastic Polyps | Non-advanced AdenomasKorea, Republic of
-
Changhai HospitalShaanxi Provincial People's Hospital; Qinghai People's Hospital; The First Affiliated... and other collaboratorsCompleted
-
Cancer Registry of NorwayUniversity of OsloActive, not recruitingColorectal Cancer | Colorectal AdenomasNorway
Clinical Trials on antioxidants
-
National Center for Complementary and Integrative...CompletedNeurological DisordersUnited States
-
Roswell Park Cancer InstituteCompleted
-
University of BelgradeActive, not recruitingPeriodontitis | Systemic SclerosisSerbia
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompletedHypertension | Insulin Resistance | Oxidative Stress | Autonomic Imbalance
-
Laboratorios OrdesaPeruvian Clinical Research; Quantum ExperimentalCompletedMalnutrition | Cystic Fibrosis | Failure to ThriveSpain, Peru
-
ScienceBased HealthCompletedPrimary Open Angle GlaucomaUnited States
-
ART Fertility Clinics LLCNot yet recruitingInfertility | In Vitro Fertilization
-
University Hospital, RouenCompleted
-
University of ThessalyARGALASTI HEALTH CENTRECompletedChronic Obstructive Pulmonary DiseaseGreece
-
National Eye Institute (NEI)Bausch & Lomb IncorporatedCompletedMacular Degeneration | Cataract | Lens Opacities